All News


All series


All All News

Gut Reaction

Immunotherapy’s effectiveness may depend on the bacteria living in patients’ gastrointestinal tracts, studies show.

The FDA has incorporated PD-L1 status into the labels for Keytruda (pembrolizumab) and Tecentriq (atezolizumab) for existing frontline approvals for platinum-ineligible patients with urothelial carcinoma, based on lower overall survival (OS) rates with the PD-1/PD-L1 inhibitors compared with platinum-based chemotherapy for patients with PD-L1–low expressing platinum-eligible urothelial carcinoma.

A cancer diagnosis means lots of treatment appointments, decisions to make and fears to face. Setting goals, whether short-term or long-term, can help get you through the journey.

Why the proverb, "you should never judge a man until you've walked a mile in his shoes" is true for both cancer patients and survivors.

I’m writing to say how much I missed you this Father’s Day. It’s hard to believe that it’s been eight years since I told you how much you mean to me in person. And to think you were so worried about my breast cancer recurring; the thought that your only child and mother of your granddaughters might suffer a long and painful death – as did your own mother – before you died yourself.

For many years, breast cancer survivors have focused their hope on the number five. With the help of their oncologists, they've taken a big sip of this medical Kool aid. But are we hoping in an untruth? This survivor shares her perspective.